1402058-22-3Relevant articles and documents
Identification of novel 3,5-diarylpyrazoline derivatives containing salicylamide moiety as potential anti-melanoma agents
Li, Qing-Shan,Zhang, Yan-Bin,Dong, Jing-Jun,Zhou, Wen-Ping,Yang, Yang,Zhu, Hai-Liang,Lv, Xian-Hai
supporting information, p. 6596 - 6601,6 (2012/12/12)
There is an accumulating body of experimental evidences validating oncogenic BRAFV600E as a therapeutic target and offering opportunities for anti-melanoma drug development. Encouraged by the positive results of pyrazole derivatives as BRAFsup